Data / Form D filings / LUREX BIO, INC
LUREX BIO, INC: Form D filings
LUREX BIO, INC, a biotechnology company in Fort Lauderdale, FL, filed 2 Form D notices with the SEC in 2026. The latest, on August 31, 2026, reports $150,000 sold of an offering with no set size to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 501 EAST LAS OLAS BLVD., SUITE 300, Fort Lauderdale, FL, 33301
- Phone
- (855) 587-3924
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2025
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 2108090
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | Amendment | Indefinite | $150,000 | 3 | Jan 22, 2026 | sec.gov | |
| Feb 5, 2026 | New notice | Indefinite | $50,000 | 1 | Jan 22, 2026 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| George Sens | Executive Officer | Chief Executive Officer |
| Mark Shumate | Executive Officer, Director | Vice President, Capital and Strategic Partnerships |
| Horace Lanier, III | Executive Officer, Director | Chief Operating Officer and Secretary |
| James Clark | Promoter | Founder; took the initiative in founding and organizing Lurex Bio, Inc. |
Other biotechnology companies in Florida that filed recently
- AdhereBio LLC offering · Oct 26, 2026
- Ascoltare Holdings LLC $1.7 million · Oct 23, 2026
- Immorta Bio, Inc. $612,503 · Oct 16, 2026
- CURADEL SURGICAL INNOVATIONS, INC. $49.8 million · Oct 13, 2026
- BioStem Technologies, Inc. $3 million · Oct 9, 2026
- HCW Biologics Inc. $1.5 million · Oct 8, 2026
Every Form D from the week of Aug 31, 2026 · All recent filings in Florida · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what LUREX BIO, INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.